As EC progresses, the tumor microenvironment gradually develops a hypoxic state, leading tumor cells to regulate metabolism by activating hypoxia-inducible factor-1α (HIF-1α) to adapt to adverse conditions. The gene discussed is HIF1A; the disease is neoplasm.